1 / 5

US Onychomycosis Market (Prescription Drugs) Size, 2016 Trends & 2020 Forecasts

The report entitled “The US Onychomycosis Market: Size, Trends & Forecasts (2016-2020)”, provides analysis of the US onychomycosis market, with detailed analysis of market size and growth, market share and economic impact of the industry. The analysis includes the market by value, by volume and by segments. The report also includes the detailed analysis of the segments of the onychomycosis market, comprising of market by value, by volume and by average prices. Complete report on Onychomycosis market spread across 67 pages providing 4 company profiles and 3 tables and 31 figures is now available at http://www.marketreportsonline.com/491816.html.

calebjackson
Download Presentation

US Onychomycosis Market (Prescription Drugs) Size, 2016 Trends & 2020 Forecasts

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The US Onychomycosis Market: Size, Trends & Forecasts (2016-2020) Published: July 2016 Pages: 67 Price: US$ 800 (Single User License) E-mail: sales@marketreportsonline.com Tel: + 1 888 391 5441

  2. The US Onychomycosis Market: Size, Trends & Forecasts (2016-2020) Scope of the Report The report entitled “The US Onychomycosis Market: Size, Trends & Forecasts (2016-2020)”, provides analysis of the US onychomycosis market, with detailed analysis of market size and growth, market share and economic impact of the industry. The analysis includes the market by value, by volume and by segments. The report also includes the detailed analysis of the segments of the onychomycosis market, comprising of market by value, by volume and by average prices. Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall onychomycosis market of the US has also been forecasted, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Valeant Pharmaceuticals, Anacor Pharmaceuticals, Novartis AG and Johnson & Johnson are some of the key players operating in the US onychomycosis market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided. Company Coverage: • Valeant Pharmaceuticals • Anacor Pharmaceuticals • Johnson & Johnson • Novartis AG http://www.marketreportsonline.com/ +1-888-391-5441

  3. The US Onychomycosis Market: Size, Trends & Forecasts (2016-2020) Executive Summary Onychomycosis is a condition of fungal nail infection. Onychomycosis begins in the nail bed and progresses to the nail plate, causing the nail to become discolored, deformed, and even separated from the nail bed. Onychomycosis has a significant chance of reoccurrence. Of all the nail abnormalities in the world, around 50% are the case of onychomycosis. In most of the cases it occurs in the toenails. Onychomycosis is not a life threatening disease but, may persist or worsen if not treated. Symptoms of onychomycosis are changes in appearance of the nail, interference with standing, walking, and exercising, pain, discomfort, etc. The causative pathogens of onychomycosis include dermatophytes (most common), Candida, and nondermatophytic molds. There are five types of Onychomycosis: Distal Subungual Onychomycosis, White superficial onychomycosis, Proximal subungual onychomycosis, Endonyx onychomycosis and Candidal onychomycosis. Two types of treatments are available of onychomycosis: Oral Treatment and Topical Treatment. Oral treatment includes: Terbinafine, Itraconazole, etc. and topical treatment includes Kerydin, Jublia, etc. Nonpharmacologic approaches are also there, which includes the following: Laser treatment, Photodynamic therapy, etc. The US onychomycosis market (prescription drugs) has increased with a healthy growth rate over the years and is expected to increase further during the forecasted period. The US onychomycosis market is supported by various growth drivers, such as rising per capita healthcare expenditure, increasing diabetic patients, ageing population, introduction of new drugs, etc. Yet, the market faces certain challenges, such as, reimbursements, low awareness, side effects, etc.

  4. The US Onychomycosis Market: Size, Trends & Forecasts (2016-2020) 1. Executive Summary 2. Introduction 2.1 Onychomycosis: An Overview 2.2 Types of Onychomycosis 2.3 Treatment For Onychomycosis 3. US Market Analysis 3.1 US Onychomycosis Market by Prevalence 3.2 US Nail Care Market: An Analysis 3.3 US Kerydin Drug Market: An Anlalysis 3.4 US Jublia Drug Market: An Analysis 3.5 US Generic Drugs Market: An Analysis 4. Market Dynamics 4.1 Growth Drivers 4.2 Challenges 4.3 Market Trends 5. Competitive Landscape 6. Company Profiling Explore More Related Reports on

  5. Global Thalassemia Market Report: 2016 Edition The US Onychomycosis Market: Size, Trends & Forecasts (2016-2020) About Us: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. Contact Us: Ritesh Tiwari UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra, India Tel: + 1 888 391 5441 E-mail: sales@marketreportsonline.com http://www.marketreportsonline.com/

More Related